Skip to content
Screener

R&D at other companies

Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$679K-85.6%
Schering-Plough logo
Schering-PloughSGP
$8.54M+41.1%
Deere & Company logo
Deere & CompanyDE
$583M+6.2%
Roblox logo
RobloxRBLX
$422M+12.8%
Salesforce logo
SalesforceCRM
$1.63B+11.4%
Analog Devices logo
Analog DevicesADI
$509.32M+15.3%

Segments

By segment

See full
Bioleum$1.92M
Corporate And Other$162.1K-37.6%

Other financials

Income statement

See full
Revenue$272.8K-19.7%
Gross profit-$896.1K-88.9%
Operating income-$26.9M-251%
Net income-$25.5M-225%
EPS (diluted)-$3.01-450%

Balance sheet

See full
Cash & equivalents$31.4M+69.0%
Total debt$19.4M+4.0%
Total equity$137.3M+55.1%
Total assets$193.5M+30.6%

Cash flow

See full
Operating cash flow-$10.1M-110%
CapEx--100%
Free cash flow-$3.5M+2.7%

Valuation

See full
Market cap$245.46M+150%
Enterprise value$233.46M+137%
P/S241.9×+212×

Profitability

See full
Gross margin-165.6%-200pp
Operating margin-5,846.1%-8,341pp
Net margin-6,012.3%-9,757pp
FCF margin-462.3%-171pp

Returns & leverage

See full
Return on equity-54%-8.7pp
Debt / equity0.1×-0.1×
Current ratio3.2×+1.7×

Where this comes from

Reported directly by Comstock Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Comstock Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-024304
Line itemThree-Months Ended / June 30, 2026Three-Months Ended / June 30, 2025Six-Months Ended / June 30, 2026Six-Months Ended / June 30, 2025
Cost of goods sold1,168,897814,0011,768,7071,700,797
Operating Expenses:
Selling, general and administrative expenses7,349,6704,635,09013,918,4437,893,555
Research and development2,284,3632,120,6454,380,6055,424,563
Depreciation and amortization1,020,760636,6922,412,1441,012,076
Loss on intangible assets impairment13,648,04213,648,042
Loss on property, plant and equipment impairment1,736,4811,736,481
Gain on sale of royalty and mineral rights(200,000)(1,400,010)(200,000)

Document

FAQ

What is Comstock Inc.'s R&D?
Comstock Inc. (LODE) reported R&D of $2.28M in Q2 2026.
How has Comstock Inc.'s R&D changed year-over-year?
Comstock Inc.'s R&D increased by 7.7% year-over-year, from $2.12M to $2.28M.
What is the long-term trend for Comstock Inc.'s R&D?
Over 4 years (2021 to 2025), Comstock Inc.'s R&D has grown at a 133.5% compound annual growth rate (CAGR), from $414.75K to $12.32M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about Comstock Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude